Clinical Trial Technology And Services Market Size, Share & Trends Analysis Report By Technology Solutions (Technology Solutions, Services), By Clinical Trial Phases (Phase I, Phase II), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Clinical Trial Technology And Services Market Growth & Trends

The global clinical trial technology and services market size is anticipated to reach USD 60.81 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a notable CAGR of 15.5% from 2025 to 2030. Major factors driving the market growth include the increasing complexity of clinical trials, the growing adoption of digital health technologies, the need for more efficient patient recruitment, and regulatory support promoting innovation.

The increasing volume of preclinical drug candidates and active clinical trials is a significant driver for market growth. With pharmaceutical and biotech companies continuously advancing new compounds from research to approval, the demand for efficient trial management, data collection, and digital solutions is rising.

The preclinical pipeline has reached an all-time high, ensuring a steady flow of compounds transitioning to clinical trials after approximately 3–4 years of development. This surge necessitates robust trial management platforms, patient recruitment solutions, and AI-powered analytics to streamline clinical operations. In addition, Contract Research Organizations (CROs) are witnessing sustained demand for clinical trial services as pharmaceutical firms invest heavily in trial execution, further boosting the adoption of decentralized trial solutions, remote monitoring technologies, and AI-driven analytics.

Technological advancements, including AI, ML, and big data analytics, are revolutionizing clinical trial management by enabling precise patient matching through data from EHRs and other sources. These innovations improve efficiency and data quality and ensure accurate, reliable trial outcomes.

Regulatory agencies aim to accelerate drug development, with programs like the FDA's Breakthrough Therapy Designation fast-tracking drug reviews. Sponsors are under pressure to improve trial designs and recruitment, creating a demand for clinical trial technology to meet regulatory standards and ensure swift patient enrollment.

Moreover, key players in the market, such as IBM, Antidote Technologies, Inc., NXGN Management, LLC, Clario, Advarra, and ArisGlobal, among others, are engaging in strategic initiatives such as partnerships, collaborations, new product launches, acquisitions, and expansions to strengthen their market position. For instance, in February 2024, ICON plc, a provider of drug development services for the pharmaceutical, biotechnology, and medical device sectors, acquired Clinical Research Management, Inc. (ClinicalRM).

Clinical Trial Technology And Services Market Report Highlights

• Based on technology solutions, the data collection and analytics segment dominated the market and held the largest revenue share of 66.54% in 2024 due to the growing need for accurate, real-time insights.
• Based on clinical trial phases, the phase III segment held the largest market share of 53.39% in 2024 and is anticipated to be the fastest-growing segment over the forecast period due to its critical role in determining the safety and efficacy of new treatments.
• Based on end use, the pharmaceutical and biotechnology firms segment held the largest market share in 2024, driven by their substantial involvement in clinical research and drug development.
• North America dominated the market with a revenue share of 43.59% in 2024, owing to the region’s advanced healthcare infrastructure and a supportive regulatory environment guided by the FDA and Health Canada encourage the adoption of digital solutions that improve trial efficiency and regulatory compliance.